
UK-based healthcare comms agency Virgo Health has launched a PR office in New York and appointed Nancy Caravetta to head …

Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …

Creative agency PAN has appointed two new account handlers in Rosemary Behan (pictured) who joins as account director, and Margaux …

The Royal Bank of Scotland’s chairman Sir Philip Hampton has been appointed by GlaxoSmithKline to succeed Sir Christopher Gent in …

AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …

London-based drug development firm Avillion has confirmed the appointment of Jarrod Longcor as its chief business officer. Longcor joins as …
The FDA is reviewing Otsuka and Lundbeck’s brexpiprazole for the treatment of schizophrenia and as an adjunctive therapy for the …

Boehringer Ingelheim is to cut around 600 of its staff in Germany as part of a drive to reduce costs …

The Labour Opposition party has set out its plans to ‘save and transform’ the NHS and has made this the key …

Contract research organisation Novella Clinical has appointed Dr Deepak Dhami as the director of its clinical monitoring unit for Europe. …

The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …

NHS England has launched a new ‘comparison website tool’ that allows health and social care organisations to see how their …

A smartphone application being developed is likely to be able to help healthcare providers and parents detect signs of jaundice …
US biopharma firm Synageva has appointed Robert Bazemore as its chief operating officer. Reporting directly to the president and chief …
Public health experts are meeting today to discuss whether boys as well as girls should be offered the HPV jab. …
A new survey commissioned by Hermes Pharma, which develops easier-to-swallow pills, has found that more than half of those asked …
Merck KGaA has swooped in and bought US-based Sigma-Aldrich in a deal worth $17 billion (€13.1 billion). The acquisition will …

A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …

Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further …